More about
Hepatocellular Carcinoma
News
February 26, 2021
3 min read
Save
Q&A: Longest survival among HCC patients seen with ‘breakthrough’ drug combination
In an exclusive interview with Healio Gastroenterology, Richard Finn, MD, discussed the results from a recent study of patients with hepatocellular carcinoma treated with combination therapy comprising atezolizumab, an immunotherapy drug and monoclonal antibody, and bevacizumab, another monoclonal antibody against the vascular endothelial growth factor (VEGF).
News
February 25, 2021
4 min read
Save
Current liver cancer screening protocols may miss at-risk Black individuals with HCV
News
February 17, 2021
2 min read
Save
Incidence of liver cancer increases significantly among people with HIV
News
January 19, 2021
4 min read
Save
Pembrolizumab shows promising OS for previously untreated advanced HCC
News
January 19, 2021
4 min read
Save
Atezolizumab-bevacizumab combination provides ‘longest survival seen’ in advanced HCC
News
January 15, 2021
1 min read
Save
Validated risk score predicts post-transplant survival in HCC
News
January 13, 2021
1 min read
Save
Endoscopic biliary drainage leads to high technical success rate in HCC
News
January 08, 2021
3 min read
Save
7 recent reports in hepatology
News
January 07, 2021
1 min read
Save
Alcohol-related liver disease increases risk for cancer
News
December 30, 2020
1 min read
Save